DES implantation in saphenous vein and left internal mammary grafts

Minerva Cardioangiologica

Volumn 56, Issue 1, 2008, Pages 79-87

  Presbitero, P ^a   Zavalloni, D ^a   Pagnotta, P ^a   Belli, G ^a   Rossi, M L ^a   Gasparini, G L ^a   Lisignoli, V ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Coronary artery bypass; Coronary restenosis; Drug eluting stents; Myocardial revascularization

Indexed keywords

'TAXUS'; CYPHER; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG;

BRACHYTHERAPY; CORONARY ARTERY BYPASS GRAFT; DISEASE COURSE; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; REVIEW; SAPHENOUS VEIN; VEIN GRAFT DISEASE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS; SAPHENOUS VEIN; TREATMENT OUTCOME;

EID: 42049099657     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Hannan EL, Racz MJ, Walfard G, Jones RH, Ryan TJ, Bennett E et al. Long-term outcomes of coronary artery bypass grafting versus stent implantation. N Engl J Med 2005;352:2174-83.
2. FitzGibbon GM, Leach AJ, Kafka HP, Keon WJ. Coronary bypass graft fate: long-term angiographic study. J Am Coll Cardiol 1991;17:1075-80.
3. Di Mauro M, Iacò AL, Contini M, Teodori G, Vitolla G, Pano M et al. Reoperative coronary artery bypass grafting:analysis of early and late outcomes. Ann Thorac Surg 2005;79:81-7.
4. Hiscock M, Oqueli E, Dick R. Percutaneous saphenous vein graft intervention - a review. Heart Lung Circ 2007;16:S51-S55.
5. Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB 3rd, Werner JA et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med 1997;337:740-7.
6. Wong SC, Baim DS, Schatz RA, Teirstein PS, King SB 3rd, Curry RC Jr et al. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group. J Am Coll Cardiol 1995;26:704-12
7. Gruberg L, Dangas G, Mehran R, Hong MK, Waksman R, Mintz GS et al. Percutaneous revascularization of the internal mammary artery graft: short- and long-term outcomes. J Am Coll Cardiol 2000;35:944-8.
8. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M et al. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
9. Regar E, Serruys PW, Bode C, Holubarsch C, Guermonprez JL, Wijns W et al. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation 2002;106:1949-56.
10. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003;108:788-94.
11. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004;109:1366-70.
12. Ong AT, Serruys PW, Aoki J, Hoye A, van Mieghem CA, Rodriguez-Granillo GA et al. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry.J Am Coll Cardiol 2005;45:1135-41.
13. Neumann FJ, Desmet W, Grube E, Brachmann J, Presbitero P, Rubartelli P et al. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 2005;111:2107-11.
14. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006;295:1253-63.
15. Iijima R, Ndrepepa G, Mehilli J, Markwardt C, Bruskina O, Pache J et al. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Am Heart J 2007;154:688-93.
16. Li JJ, Xu B, Yang YJ, Chen JL, Qiao SB, Ma WH et al. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent. Chin Med J (Engl) 2007;120:569-73.
17. Ge L, Iakovou I, Sangiorgi GM, Chieffo A, Melzi G, Cosgrave J et al. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome. J Am Coll Cardiol 2005;45:989-94.
18. Chu WW, Rha SW, Kuchulakanti PK, Cheneau E, Torguson R, Pinnow E et al. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 2006;97:34-7.
19. Lee MS, Shah AP, Aragon J, Jamali A, Dohad S, Kar S et al. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv 2005;66:507-11.
20. Bansal D, Muppidi R, Singla S, Sukhija R, Zarich S, Mehta JL et al. Percutaneous intervention on the saphenous vein bypass grafts - long-term outcomes. Catheter Cardiovasc Interv 2008;71:58-61.
21. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol 2006;48:2423-31.
22. Chu WW, Kuchulakanti PK, Wang B, Clavijo LC, Suddath WO, Pichard AD et al. Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention. J Interv Cardiol 2006;19:121-5.
23. Mishra S, Wolfram RM, Torguson R, Chu WW, Xue Z, Gevorkian N et al. Comparison of effectiveness and safety of drug-eluting stents versus vascular brachytherapy for saphenous vein graft in-stent restenosis. Am J Cardiol. 2006;97:1303-7.
24. Buch AN, Xue Z, Gevorkian N, Torguson R, Foumadjieva J, Deible R et al. Comparison of outcomes between bare metal stents and drug-eluting stents for percutaneous revascularization of internal mammary grafts. Am J Cardiol 2006; 98(6):722-4.
25. Zavalloni D, Rossi ML, Scatturin M, Morenghi E, Soregaroli D, Municinò A et al. Drug-eluting stents for the percutaneous treatment of the anastomosis of the left internal mammary graft to left anterior descending artery. Coron Artery Dis 2007;18:495-500.
26. Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-47.
27. van Beusekom HM, van der Giessen WJ, van Suylen R, Bos E, Bosman FT, Serruys PW. Histology after stenting of human saphenous vein bypass grafts: observations from surgically excised grafts 3 to 320 days after stent implantation. J Am Coll Cardiol 1993;21:45-54.
28. Douglas JS Jr. Percutaneous approaches to recurrent myocardial ischemia in patients with prior surgical revascularization. Semin Thorac Cardiovasc Surg 1994;6:98-108.
29. Shah PJ, Durairaj M, Gordon I, Fuller J, Rosalion A, Seevanayagam S et al. Factors affecting patency of internal thoracic artery graft: clinical and angiographic study in 1434 symptomatic patients operated between 1982 and 2002. Eur J Cardiothorac Surg 2004;26:11-8-24.
30. Cameron A, Davis KB, Green GE, Myers WO, Pettinger M. Clinical implications of internal mammary artery bypass grafts: the Coronary Artery Surgery Study experience. Circulation 1988;77:815-9.
31. Shimshak TM, Giorgi LV, Johnson WL, McConahay DR, Rutherford BD, Ligon R et al. Application of percutaneous transluminal coronary angioplasty to the internal mammary artery graft. J Am Coll Cardiol 1988;12:1205-14.
32. Ishizaka N, Ishizaka Y, Ikari Y, Isshiki T, Tamura T, Suma H et al. Initial and subsequent angiographic outcome of percutaneous transluminal angioplasty performed on internal mammary artery grafts. Br Heart J 1995;74:615-9.
33. Hearne SE, Davidson CJ, Zidar JP Phillips HR, Stack RS, Sketch MH Jr. Internal mammary artery graft angioplasty: acute and long-term outcome. Cathet Cardiovasc Diagn 1998;44:153-6.
34. Eisenberg MJ, Konnyu KJ. Review of randomized clinical trials of drug-eluting stents for the prevention of instent restenosis. Am J Cardiol 2006;98:375-82.
35. Mestres CA, Rives A, Igual A, Vehi C, Murtra M. Atherosclerosis of the internal mammary artery. Histopathological analysis and implications on its results in coronary artery bypass graft surgery. Thorac Cardiovasc Surg 1986;34:356-8.
36. Arciniegas E, Fermin E, Tortoledo F Vasquez JR Bello A. Characterization of the atherosclerotic plaque in the internal mammary artery. Cathet Cardiovasc Diagn 1998;43:413-20.